184 related articles for article (PubMed ID: 26962160)
1. Chemotherapy for Bone Sarcoma in Adults.
Wagner MJ; Livingston JA; Patel SR; Benjamin RS
J Oncol Pract; 2016 Mar; 12(3):208-16. PubMed ID: 26962160
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for bone sarcomas in adults: the MD anderson experience.
Benjamin RS; Wagner MJ; Livingston JA; Ravi V; Patel SR
Am Soc Clin Oncol Educ Book; 2015; ():e656-60. PubMed ID: 25993237
[TBL] [Abstract][Full Text] [Related]
3. Use of chemotherapy for patients with bone and soft-tissue sarcomas.
Wesolowski R; Budd GT
Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S23-6. PubMed ID: 20179184
[TBL] [Abstract][Full Text] [Related]
4. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapeutic concepts for bone sarcomas].
Kager L; Bielack S
Unfallchirurg; 2014 Jun; 117(6):517-22. PubMed ID: 24903502
[TBL] [Abstract][Full Text] [Related]
6. Standard chemotherapy for malignant bony tumors in children and young adults.
Rafique A; Kent PM
Curr Probl Cancer; 2013; 37(4):207-14. PubMed ID: 24238586
[No Abstract] [Full Text] [Related]
7. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?
Carter SK
J Clin Oncol; 1984 Mar; 2(3):147-8. PubMed ID: 6583329
[No Abstract] [Full Text] [Related]
9. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
[No Abstract] [Full Text] [Related]
11. Advances in the Treatment of Pediatric Bone Sarcomas.
Grohar PJ; Janeway KA; Mase LD; Schiffman JD
Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of malignant bone tumors].
Höffken K; Seeber S; Gallmeier WM; Bruntsch U; Hossfeld DK; Schmidt CG
Chirurg; 1977 Apr; 48(4):274-9. PubMed ID: 324726
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
Just MA; Van Mater D; Wagner LM
Pediatr Blood Cancer; 2021 Aug; 68(8):e29084. PubMed ID: 33894051
[TBL] [Abstract][Full Text] [Related]
14. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
16. [The role of polychemotherapy in the management of malignant bone tumors].
Reichardt P; Dörken B
Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy in primary osteogenic sarcoma in patients over the age of forty.
Ozkurt B; Basarir K; Yalcin B; Merter A; Yildiz Y; Saglik Y
Acta Orthop Traumatol Turc; 2017 Mar; 51(2):123-127. PubMed ID: 28214261
[TBL] [Abstract][Full Text] [Related]
18. Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience.
Bruland ØS; Bauer H; Alvegaard T; Smeland S
Cancer Treat Res; 2009; 152():309-18. PubMed ID: 20213398
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
20. Current concepts on the molecular biology of osteosarcoma.
Gorlick R
Cancer Treat Res; 2009; 152():467-78. PubMed ID: 20213409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]